A randomized comparison of sirolimus- versus paclitaxel-eluting stent implantation in patients with diabetes mellitus: 4-year clinical outcomes of DES-DIABETES (Drug-Eluting Stent in patients with DIABETES mellitus) trial

JACC: Cardiovascular Interventions

Volumn 4, Issue 3, 2011, Pages 310-316

  Lee, Seung Whan ^a   Park, Seong Wook ^a   Kim, Young Hak ^a   Yun, Sung Cheol ^a   Park, Duk Woo ^a   Lee, Cheol Whan ^a   Kang, Soo Jin ^a   Rhee, Kyoung Suk ^b   Chae, Jei Keon ^b   Ko, Jae Ki ^b   Park, Jae Hyeong ^c   Lee, Jae Hwan ^c   Choi, Si Wan ^c   Jeong, Jin Ok ^c   Seong, In Whan ^c   Cho, Yoon Haeng ^d   Lee, Nae Hee ^d   Kim, June Hong ^e   Chun, Kook Jin ^e   Kim, Hyun Sook ^f   Park, Seung Jung ^a   more..

^a University of Ulsan College of Medicine   (South Korea)

^b Chonbuk National University Medical School   (South Korea)

^c Chungnam National University College of Medicine   (South Korea)

^d Soonchunhyang University   (South Korea)

^e Pusan National University Yangsan Hospital   (South Korea)

^f Hallym University   (South Korea)

Author keywords

coronary artery disease; diabetes mellitus; paclitaxel eluting stent(s); sirolimus eluting stent(s)

Indexed keywords

ANTITHROMBOCYTIC AGENT; FIBRINOGEN RECEPTOR ANTAGONIST; GLYCERYL TRINITRATE; INSULIN; ORAL ANTIDIABETIC AGENT; PACLITAXEL; RAPAMYCIN;

ADULT; ANGIOCARDIOGRAPHY; ARTERY DIAMETER; ARTICLE; BARE METAL STENT; DEATH; DIABETES MELLITUS; DIABETIC PATIENT; DRUG EFFICACY; DRUG ELUTING STENT; DRUG SAFETY; FEMALE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; HYPERCHOLESTEROLEMIA; IMPLANT; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; Q WAVE; RANDOMIZED CONTROLLED TRIAL; REVASCULARIZATION; STENT THROMBOSIS; TREATMENT OUTCOME; ULTRASOUND;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CARDIOVASCULAR AGENTS; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; DIABETES MELLITUS; DRUG-ELUTING STENTS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PACLITAXEL; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; REPUBLIC OF KOREA; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SIROLIMUS; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 79953016174     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2010.12.006     Document Type: Article

References (34)

1. K.E. Kip, D.P. Faxon, K.M. Detre, W. Yeh, S.F. Kelsey, and J.W. Currier Coronary angioplasty in diabetic patients The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry Circulation 94 1996 1818 1825 (Pubitemid 26349292)
2. S.R. Wilson, B.A. Vakili, W. Sherman, T.A. Sanborn, and D.L. Brown Effect of diabetes on long-term mortality following contemporary percutaneous coronary intervention: analysis of 4,284 cases Diabetes Care 27 2004 1137 1142 (Pubitemid 38579779)
3. A. Abizaid, R. Kornowski, and G.S. Mintz The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation J Am Coll Cardiol 32 1998 584 589 (Pubitemid 28435240)
4. R. Kornowski, G.S. Mintz, and K.M. Kent Increase restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia: a serial intravascular study Circulation 95 1997 1366 1369 (Pubitemid 27142791)
5. M. Sabate, P. Jimenez-Quevedo, and D.J. Angiolillo Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (DIABETES) trial Circulation 112 2005 2175 2183 (Pubitemid 41475813)
6. P. Ortolani, M. Balducelli, and P. Marzaroli Two-year clinical outcomes with drug-eluting stents for diabetic patients with de novo coronary lesions: results from a real-world multicenter registry Circulation 117 2008 923 930 (Pubitemid 351272590)
7. P. Jimnez-Quevedo, M. Sabat, and D.J. Angiolillo Long-term clinical benefit of sirolimus-eluting stent implantation in diabetic patients with de novo coronary stenoses: long-term results of the DIABETES trial Eur Heart J 28 2007 1946 1952 (Pubitemid 47579538)
8. A.J. Scheen, F. Warzee, and V.M. Legrand Drug-eluting stents: meta-analysis in diabetic patients Eur Heart J 25 2004 2168 2169
9. P.A. Lemos, P.W. Serruys, and R.T. van Domburg Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world": the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) Registry Circulation 109 2004 190 195 (Pubitemid 38114138)
10. J. Daemen, H.M. Garcia-Garcia, and N. Kukreja The long-term value of sirolimus- and paclitaxel-eluting stents over bare metal stents in patients with diabetes mellitus Eur Heart J 28 2007 26 32 (Pubitemid 46134954)
11. S.J. Hong, M.H. Kim, and T.H. Ahn Multiple predictors of coronary restenosis after drug-eluting stent implantation in patients with diabetes Heart 92 2006 1119 1124 (Pubitemid 44125234)
12. R. Kumar, T.T. Lee, and A. Jeremias Comparison of outcomes using sirolimus-eluting stenting in diabetic versus nondiabetic patients with comparison of insulin versus non-insulin therapy in the diabetic patients Am J Cardiol 100 2007 1187 1191 (Pubitemid 47498276)
13. J. Daemen, H.M. Garcia-Garcia, and N. Kukreja The long-term value of sirolimus- and paclitaxel-eluting stents over bare metal stents in patients with diabetes mellitus Eur Heart J 28 2007 26 32 (Pubitemid 46134954)
14. E. Mahmud, G. Bromberg-Marin, V. Palakodeti, L. Ang, D. Creanga, and A.N. Demaria Clinical efficacy of drug-eluting stents in diabetic patients: a meta-analysis J Am Coll Cardiol 51 2008 2385 2395 (Pubitemid 351815166)
15. P. Roy, L. Bonello, and A. de Labriolle Two-year outcome of patients treated with sirolimus-versus paclitaxel-eluting stents in an unselected population with coronary artery disease (from the REWARDS Registry) Am J Cardiol 102 2008 292 297
16. A. Dibra, A. Kastrati, and J. Mehilli Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients N Engl J Med 353 2005 663 670 (Pubitemid 41175674)
17. T.H. Yang, S.W. Park, and M.K. Hong Impact of diabetes mellitus on angiographic and clinical outcomes in the drug-eluting stents era Am J Cardiol 96 2005 1389 1392
18. S.W. Lee, S.W. Park, and Y.H. Kim A randomized comparison of sirolimus-versus paclitaxel-eluting stent implantation in patients with diabetes mellitus J Am Coll Cardiol 52 2008 727 733
19. S.W. Lee, S.W. Park, and Y.H. Kim A randomized comparison of sirolimus-versus paclitaxel-eluting stent implantation in patients with diabetes mellitus 2-year clinical outcomes of the DES-DIABETES trial J Am Coll Cardiol 53 2009 812 813
20. M.C. Morice, A. Colombo, and B. Meier Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial JAMA 295 2006 895 904
21. I. Iakovou, T. Schmidt, and E. Bonizzoni Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents JAMA 293 2005 2126 2130 (Pubitemid 40617065)
22. D.W. Park, S.W. Park, and K.H. Park Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up Am J Cardiol 98 2006 352 356
23. K.C. Cain, and N.T. Lange Approximate case influence for the proportional hazards regression model with censored data Biometrics 40 1984 493 499 (Pubitemid 15269246)
24. Räber L. 5-year clinical and angiographic follow-up from a prospective, randomized trial comparing sirolimus-eluting with paclitaxel-eluting stents. TCT September 23, 2009, late breaking trial session.
25. S.W. Lee, S.W. Park, and Y.H. Kim Drug-eluting stenting followed by cilostazol treatment reduces late restenosis in patients with diabetes mellitus the DECLARE-DIABETES Trial (A Randomized Comparison of Triple Antiplatelet Therapy with Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Diabetic Patients) J Am Coll Cardiol 51 2008 1181 1187
26. C.W. Lee, D.W. Park, and B.K. Lee Predictors of restenosis after placement of drug-eluting stents in one or more coronary arteries Am J Cardiol 97 2006 506 511 (Pubitemid 43190041)
27. R. Wessely, A. Kastrati, and A. Schmig Late restenosis in patients receiving a polymer-coated sirolimus-eluting stent Ann Intern Med 143 2005 392 394 (Pubitemid 41266615)
28. C. Stettler, S. Wandel, and S. Allemann Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis Lancet 370 2007 937 948 (Pubitemid 47393576)
29. P.W. Serruys, Y. Onuma, and S. Garg 5-year clinical outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesions J Am Coll Cardiol 55 2010 1093 1101
30. C.W. Lee, S.J. Kang, and D.W. Park Intravascular ultrasound findings in patients with very late stent thrombosis after either drug-eluting or bare-metal stent implantation J Am Coll Cardiol 55 2010 1936 1942
31. J.A. Ormiston, P.W. Serruys, and E. Regar A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial Lancet 371 2008 899 907 (Pubitemid 351384734)
32. J.J. Wykrzykowska, Y. Onuma, and P.W. Serruys Advances in stent drug delivery: the future is in bioabsorbable stents Expert Opin Drug Deliv 6 2009 113 126
33. S.D. Wiviott, E. Braunwald, and C.H. McCabe Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON TIMI 38 trial: a subanalysis of a randomised trial Lancet 371 2008 1353 1363
34. F.J. Wackers, L.H. Young, and S.E. Inzucchi Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD Study Diabetes Care 27 2004 1954 1961 (Pubitemid 38989238)